Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Antipsychotic therapy and short-term serious events in older adults with dementia.

Rochon PA, Normand SL, Gomes T, Gill SS, Anderson GM, Melo M, Sykora K, Lipscombe L, Bell CM, Gurwitz JH.

Arch Intern Med. 2008 May 26;168(10):1090-6. doi: 10.1001/archinte.168.10.1090.

PMID:
18504337
2.

Antipsychotic drug use and mortality in older adults with dementia.

Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA.

Ann Intern Med. 2007 Jun 5;146(11):775-86.

PMID:
17548409
3.

Older men with dementia are at greater risk than women of serious events after initiating antipsychotic therapy.

Rochon PA, Gruneir A, Gill SS, Wu W, Fischer HD, Bronskill SE, Normand SL, Austin PC, Seitz DP, Bell CM, Fu L, Lipscombe L, Anderson GM, Gurwitz JH.

J Am Geriatr Soc. 2013 Jan;61(1):55-61. doi: 10.1111/jgs.12061. Epub 2013 Jan 10.

PMID:
23301833
4.

Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults.

Lee PE, Sykora K, Gill SS, Mamdani M, Marras C, Anderson G, Shulman KI, Stukel T, Normand SL, Rochon PA.

J Am Geriatr Soc. 2005 Aug;53(8):1374-9.

PMID:
16078964
5.

Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.

Mehta S, Johnson ML, Chen H, Aparasu RR.

J Clin Psychiatry. 2010 Jun;71(6):689-98. doi: 10.4088/JCP.09m05817yel.

PMID:
20573328
6.

Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact.

Bronskill SE, Anderson GM, Sykora K, Wodchis WP, Gill S, Shulman KI, Rochon PA.

J Am Geriatr Soc. 2004 May;52(5):749-55.

PMID:
15086656
7.

Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA.

N Engl J Med. 2005 Dec 1;353(22):2335-41.

8.

Atypical antipsychotics and parkinsonism.

Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH.

Arch Intern Med. 2005 Sep 12;165(16):1882-8.

PMID:
16157833
9.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
10.

Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents.

Lane CJ, Bronskill SE, Sykora K, Dhalla IA, Anderson GM, Mamdani MM, Gill SS, Gurwitz JH, Rochon PA.

J Am Geriatr Soc. 2004 Jun;52(6):861-6.

PMID:
15161447
11.

Exploring the association between atypical neuroleptic agents and diabetes mellitus in older adults.

Etminan M, Streiner DL, Rochon PA.

Pharmacotherapy. 2003 Nov;23(11):1411-5.

PMID:
14620387
12.

Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.

Aparasu RR, Jano E, Johnson ML, Chen H.

Am J Geriatr Pharmacother. 2008 Oct;6(4):198-204. doi: 10.1016/j.amjopharm.2008.10.003.

PMID:
19028375
13.

Antipsychotic use and the risk of diabetes in nursing home residents with dementia.

Jalbert JJ, Daiello LA, Eaton CB, Miller SC, Lapane KL.

Am J Geriatr Pharmacother. 2011 Jun;9(3):153-63. doi: 10.1016/j.amjopharm.2011.04.006. Epub 2011 May 19.

PMID:
21596626
14.

Antipsychotic drug use and risk of pneumonia in elderly people.

Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC.

J Am Geriatr Soc. 2008 Apr;56(4):661-6. doi: 10.1111/j.1532-5415.2007.01625.x. Epub 2008 Feb 7.

PMID:
18266664
15.

Variation in nursing home antipsychotic prescribing rates.

Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K, Wodchis WP, Hillmer M, Kopp A, Gurwitz JH, Anderson GM.

Arch Intern Med. 2007 Apr 9;167(7):676-83.

PMID:
17420426
16.

The relationship between variations in antipsychotic prescribing across nursing homes and short-term mortality: quality of care implications.

Bronskill SE, Rochon PA, Gill SS, Herrmann N, Hillmer MP, Bell CM, Anderson GM, Stukel TA.

Med Care. 2009 Sep;47(9):1000-8. doi: 10.1097/MLR.0b013e3181a3943f.

PMID:
19648835
17.

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study.

Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N, Normand SL, Gurwitz JH, Marras C, Wodchis WP, Mamdani M.

BMJ. 2005 Feb 26;330(7489):445. Epub 2005 Jan 24.

18.

Outcomes of antipsychotic drug use in community-dwelling elders with dementia.

Kolanowski A, Fick D, Waller JL, Ahern F.

Arch Psychiatr Nurs. 2006 Oct;20(5):217-25.

PMID:
17010825
19.

Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.

Daiello LA, Ott BR, Lapane KL, Reinert SE, Machan JT, Dore DD.

Am J Geriatr Pharmacother. 2009 Apr;7(2):74-83. doi: 10.1016/j.amjopharm.2009.04.002.

PMID:
19447360
20.

Current issues in dementia pharmacotherapy.

Daiello LA.

Am J Manag Care. 2007 Dec;13 Suppl 8:S198-202. Review.

Supplemental Content

Support Center